Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal analysis of antibody decay in convalescent COVID-19 patients
Weiming Xia, Mingfei Li, Ying Wang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories
Yong Ge, Wenbin Zhang, Xilin Wu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 89
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals
Stanley C. Jordan, Bong‐Ha Shin, Terry‐Ann M. Gadsden, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 11, pp. 2554-2556
Open Access | Times Cited: 84
A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples
Yanan Tang, Turun Song, Lu Gao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
Benjamin A. Krishna, Eleanor Y. Lim, Lenette Mactavous, et al.
EBioMedicine (2022) Vol. 81, pp. 104129-104129
Open Access | Times Cited: 34
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination
Stefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
EBioMedicine (2024) Vol. 105, pp. 105180-105180
Open Access | Times Cited: 6
Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
Tulio J. Lopera, Mateo Chvatal-Medina, Lizdany Flórez‐Álvarez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
A comparative cost assessment of coalescing epidemic control strategies in heterogeneous social-contact networks
Jan Broekaert, Davide La Torre, Faizal Hafiz, et al.
Computers & Operations Research (2024) Vol. 167, pp. 106680-106680
Closed Access | Times Cited: 3
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy
Daniel Sidler, Alexander Born, Simeon Schietzel, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002166-e002166
Open Access | Times Cited: 16
Waning, Boosting and a Path to Endemicity for SARS-CoV-2
Matt J. Keeling, Amy Thomas, Edward M. Hill, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern
Ivan Odak, Christian Schultze-Florey, Swantje I. Hammerschmidt, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)
Ai Phuong Tran, Daniel Tassone, Nik S. Ding, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002871-e002871
Open Access | Times Cited: 5
Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months
Tsuf Eyran, Anna Vaisman‐Mentesh, David Taussig, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010569-e1010569
Open Access | Times Cited: 9
Modeling in higher dimensions to improve diagnostic testing accuracy: Theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays
Rayanne A. Luke, Anthony J. Kearsley, Nora Pisanic, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0280823-e0280823
Open Access | Times Cited: 4
Dynamics of SARS-CoV-2-specific antibodies among COVID19 biobank donors in Argentina
Yésica Longueira, María Laura Polo, Gabriela Turk, et al.
Heliyon (2021) Vol. 7, Iss. 10, pp. e08140-e08140
Open Access | Times Cited: 9
Optimal classification and generalized prevalence estimates for diagnostic settings with more than two classes
Rayanne A. Luke, Anthony J. Kearsley, Paul N. Patrone
Mathematical Biosciences (2023) Vol. 358, pp. 108982-108982
Open Access | Times Cited: 3
Neutralizing antibodies from naturally infected individuals against SARS-CoV-2 Gamma and Delta variants in the Paraguayan population
Angélica Samudio, Pablo H. Sotelo, Pamela González-Maldonado, et al.
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 10, pp. 1407-1412
Open Access | Times Cited: 2
Blood metal analysis of plasmas from donors with and without SARS-CoV-2 using laser-induced breakdown spectroscopy and logistic regression
Noureddine Melikechi, H. Adler, Ali Safi, et al.
Biomedical Optics Express (2023) Vol. 15, Iss. 1, pp. 446-446
Open Access | Times Cited: 2
Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents
Édouard Tuaillon, Amandine Pisoni, Nicolas Veyrenche, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Longitudinal analysis of antibody trajectories and humoral responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy (RituxiVac 2.0)
Daniel Sidler, Alexander Born, Simeon Schietzel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Effect of antibody levels on the spread of disease in multiple infections
Xiangxi Li, Yuhan Li, Minyu Feng, et al.
Chaos Solitons & Fractals (2024) Vol. 185, pp. 115063-115063
Open Access
A combined neural ODE-Bayesian optimization approach to resolve dynamics and estimate parameters for a modified SIR model with immune memory
Donglin Liu, Alexandros Sopasakis
Heliyon (2024) Vol. 10, Iss. 19, pp. e38276-e38276
Open Access
Post COVID-19 War Era, Covid-19 Variants Considerably Increased Hematologic Disorders
Bahram Alamdary Badlou
Journal of Internal Medicine and Emergency Research (2023)
Open Access | Times Cited: 1
Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID‐19 infection
Dorit Blickstein, Marina Izak, Talia Filipovich‐Rimon, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 7, pp. 517-522
Closed Access | Times Cited: 1
Untangling the changing impact of non-pharmaceutical interventions and vaccination on European Covid-19 trajectories
Yong Ge, Wenbin Zhang, Xilin Wu, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 2
Postcovid-19 war era, hematologic disorders significantly increased by Covid-19 variants, mysteriously
Bahram Alamdary Badlou
Hematology & Transfusion International Journal (2023) Vol. 11, Iss. 1, pp. 27-29
Open Access
Page 1 - Next Page

Scroll to top